Researchers assessed the therapeutic equivalence of proposed biosimilar CT-P41 and reference denosumab for the treatment of postmenopausal osteoporosis.

Millions of postmenopausal women find themselves facing a diagnosis of osteoporosis, but what does that mean for their daily ...

It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Osteoporosis is a condition that causes bones to ...

"Importantly, although the most commonly considered osteoporotic fractures (hip, vertebral, forearm, humerus, and pelvis) ...

The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...

Osteoporosis is one of the common bone diseases resulted due to loss in bone mass. This disease starts developing when the body consumes more bone tissue than it produces; thus, this reduces the bone ...

Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov. 5 ... serve as diagnostic tools and potential targets for treatments. Drawing from a large database of ...

But despite this evidence, hormone therapy’s use has plummeted over the past few decades. In 1999, almost 27% of menopausal ...

Pollution may be another important risk factor for osteoporosis, in addition to poor diet, lack of exercise and smoking.

The Bon Secours’ Health Matters segment for this month focuses on Osteoporosis. It’s a condition that causes a person’s bones ...

Non-communicable diseases, including cancers such as lung, liver, and breast cancer, account for 77% of total deaths in ...